Using INK4A/ARF-null human GBM specimens, we showed that BMI1 is enriched in CD133+ cells and required to sustain their self-renewal through prevention of CD133+ cells apoptosis and/or differentiation into neurons and astrocytes [70]. The gene discussed is CDKN2A; the disease is glioblastoma.